Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF
Conditions
Pulmonary Fibrosis
What is the purpose of this trial?
Idiopathic pulmonary fibrosis (IPF) is a long-term lung disease that affects an individual's ability to breathe. This study will evaluate the effectiveness of the antioxidant N-acetylcysteine (NAC), at preventing the loss of lung function in people with IPF.
Participation Guidelines
- Age:
- 35 Years - 85 Years
- Gender:
- Both
Click here for detailed information about who can participate in this trial.
- Sponsor:
- Duke University
National Heart, Lung, and Blood Institute (NHLBI) - Dates:
- October 2009
- Last Updated:
- March 11, 2013
- Study HIC#:
- 0909005684
Clinicaltrials.gov ID: NCT00650091
